- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07632287
Effects of Standard and Modified Z-Trendelenburg Positions on Cerebral Oxygenation and Optic Nerve Sheath Diameter (MOD-TREND)
Comparison of the Effects of Standard Trendelenburg and Modified Z Trendelenburg Positions on Cerebral Oxygenation (NIRS) and Optic Nerve Sheath Diameter in Laparoscopic Gynecological Cases
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Laparoscopic surgeries frequently require patients to be placed in a steep Trendelenburg position with pneumoperitoneum to provide optimal surgical exposure. However, this combination induces significant physiological alterations, most notably an increase in intracranial pressure (ICP) and a potential compromise in cerebral venous drainage and regional cerebral oxygen saturation (rSO2). Non-invasive monitoring techniques, such as measuring the optic nerve sheath diameter (ONSD) via ultrasonography, provide reliable, real-time estimates of ICP changes. Additionally, Near-Infrared Spectroscopy (NIRS) allows for the continuous monitoring of cerebral oxygenation.
This prospective clinical study is designed to evaluate and compare the cerebral and hemodynamic impacts of the standard straight Trendelenburg position versus a modified Z-Trendelenburg position. Participants scheduled for elective laparoscopic procedures will be divided into specific positioning groups. Hemodynamic parameters, NIRS values, and ONSD measurements will be recorded at predefined time points throughout the surgery: at baseline, post-induction, after the establishment of pneumoperitoneum and positioning, at specific intervals during the surgery, and post-operatively in the recovery room. The primary hypothesis is that the modified Z-Trendelenburg position will attenuate the rise in ICP (reflected by a smaller increase in ONSD) and provide better cerebral oxygenation stability compared to the traditional standard position.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Ankara
-
Ankara, Ankara, Turquie (Türkiye), 06010
- Ankara Etlik City Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
Patients aged between 18 and 70 years
American Society of Anesthesiologists (ASA) physical status I or II
Scheduled for elective laparoscopic surgery requiring Trendelenburg position
Provided written informed consent
Exclusion Criteria:
Patient refusal to participate
History of severe cerebrovascular disease
Known increased intracranial pressure
Pre-existing ocular pathology that could affect optic nerve sheath diameter (ONSD) measurements (e.g., glaucoma, optic neuritis, ocular trauma)
Severe cardiovascular or pulmonary disease Body Mass Index (BMI) greater than 35 kg/m^2 Pregnancy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Standard Trendelenburg Cohort
Patients undergoing elective laparoscopic surgery placed in the standard straight Trendelenburg position.
|
Placement of the patient in the traditional straight head-down tilt position required for laparoscopic surgical access and pneumoperitoneum
|
|
Modified Z-Trendelenburg Cohort
Patients undergoing elective laparoscopic surgery placed in the modified Z-Trendelenburg position (head-down tilt combined with leg flexion).
|
Placement of the patient in a modified head-down tilt position combined with leg flexion
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Regional Cerebral Oxygen Saturation (rSO2)
Délai: Baseline (before anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
Regional cerebral oxygen saturation (rSO2) will be measured bilaterally using Near-Infrared Spectroscopy (NIRS) sensors placed on the patient's forehead.
This non-invasive monitoring will be used to evaluate cerebral oxygenation changes during different surgical positions and pneumoperitoneum.
Values will be recorded as percentages (%).
|
Baseline (before anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Mean Arterial Pressure (MAP)
Délai: Baseline ( 10 minutes after anesthesia induction), at 10,45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
Mean Arterial Pressure (MAP) will be continuously monitored and recorded to evaluate the cardiovascular effects of the pneumoperitoneum and modified positioning.
Values will be reported in mmHg.
|
Baseline ( 10 minutes after anesthesia induction), at 10,45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
|
Change in Optic Nerve Sheath Diameter (ONSD)
Délai: Baseline ( 10 minutes after anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
Intracranial pressure changes will be evaluated indirectly by measuring the optic nerve sheath diameter (ONSD) using ocular ultrasonography.
Measurements will be taken bilaterally and recorded in millimeters (mm).
|
Baseline ( 10 minutes after anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine position.
|
|
Change in Peak Airway Pressure (Ppeak)
Délai: Baseline (10 minutes after anesthesia induction), at 10,45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine posi
|
Peak airway pressure will be monitored continuously and recorded to evaluate the effects of pneumoperitoneum and different surgical positions on respiratory mechanics.
Values will be reported in centimeters of water (cmH2O).
|
Baseline (10 minutes after anesthesia induction), at 10,45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine posi
|
|
Change in End-tidal Carbon Dioxide (EtCO2)
Délai: Baseline (10 minutes after anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine positi
|
End-tidal carbon dioxide levels will be monitored continuously via capnography to evaluate ventilation status during pneumoperitoneum and different positioning.
Values will be reported in millimeters of mercury (mmHg).
|
Baseline (10 minutes after anesthesia induction), at 10, 45, 60, and 90 minutes after establishing pneumoperitoneum and surgical positioning, and 10 minutes after returning to the supine positi
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AEŞH-EK-2026-048
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .